Establishment and characterization of multidrug-resistant human osteosarcoma cell lines

M. Serra, K. Scotland, M. C. Manara, D. Maurici, P. L. Lollini, C. De Giovanni, G. Toffoli, N. Baldini

Research output: Contribution to journalArticlepeer-review


Multidrug resistant variants of two human osteosarcoma cell lines (U-2 OS and Saos-2) were selected by continuous exposure to doxorubicin. The in vitro and in vivo growth characteristics of these sublines as well as the expression of osteoblastic markers and of some surface antigens were analyzed. Resistant variants showed a higher doubling time and a lower cloning efficiency, and a lower metastatic ability after i.v. injection than corresponding parental cell lines. All the sublines showed overexpression of p-glycoprotein (referred to as pl70). The level of expression of this protein in the different cell lines was directly related to the degree of resistance as shown by the in vitro sensitivity to doxorubicin and other multidrug-related drugs. In sublines showing the highest levels of resistance (over 300-fold), pl70 overexpression was associated with mdr 1 gene amplification. These are the first multidrug resistant human osteosarcoma cell lines ever reported. They may be used as a model for further investigations into the mechanisms of drug resistance in osteosarcoma and as a standard for the assessment of chemosensitivity in clinical samples.

Original languageEnglish
Pages (from-to)323-329
Number of pages7
JournalAnticancer Research
Issue number2
Publication statusPublished - 1993


  • Doxorubicin
  • Multidrug resistance
  • Osteosarcoma
  • P-glycoprotein

ASJC Scopus subject areas

  • Cancer Research
  • Oncology


Dive into the research topics of 'Establishment and characterization of multidrug-resistant human osteosarcoma cell lines'. Together they form a unique fingerprint.

Cite this